Developing Pharmaceuticals
Development of Next-Generation Radiopharmaceuticals for Both Diagnosis and Treatment of Cancer, Utilizing the Copper Radioisotope 64Cu.
Developing Pharmaceuticals
Our mission is to deliver the “Innovative ‘Visible’ Cancer Treatments” to society as fast as possible, linking innovative science technology and medicine, for the happiness of patients and their families suffering from cancer and healthcare workers fighting side by side.
We believe that our innovative “visible” cancer drugs will reduce unnecessary treatments and provide optimal medical care to individual patients.
Development of Next-Generation Radiopharmaceuticals for Both Diagnosis and Treatment of Cancer, Utilizing the Copper Radioisotope 64Cu.
Developing Pharmaceuticals